Welcome to LookChem.com Sign In|Join Free
  • or
(11aR)-3-but-3-en-1-yldecahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one is a complex bicyclic chemical compound that features a diazocin ring system and a butenyl side chain. As a synthetic derivative, it is utilized in pharmaceutical research and development, with its unique structure and properties suggesting potential applications in drug discovery and medicinal chemistry. Further research and testing are essential to explore its full potential and effects.

3382-84-1

Post Buying Request

3382-84-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3382-84-1 Usage

Uses

Used in Pharmaceutical Research and Development:
(11aR)-3-but-3-en-1-yldecahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one is used as a research compound for exploring its potential applications in drug discovery and medicinal chemistry. Its unique structure and properties make it a promising candidate for the development of new therapeutic agents.
Used in Drug Discovery:
In the field of drug discovery, (11aR)-3-but-3-en-1-yldecahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one is used as a starting point for designing and synthesizing new pharmaceutical compounds. Its complex molecular structure may offer novel interactions with biological targets, leading to the development of innovative treatments for various diseases.
Used in Medicinal Chemistry:
(11aR)-3-but-3-en-1-yldecahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one is employed in medicinal chemistry as a structural template for the modification and optimization of drug candidates. Its diazocin ring system and butenyl side chain can be modified to enhance the compound's pharmacological properties, such as potency, selectivity, and bioavailability.
Note: Since the provided materials do not specify any particular application industry or reason for the use of (11aR)-3-but-3-en-1-yldecahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one, the uses listed above are general applications based on its role as a chemical compound in pharmaceutical research and development. Further information would be required to provide more specific applications.

Check Digit Verification of cas no

The CAS Registry Mumber 3382-84-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,8 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 3382-84:
(6*3)+(5*3)+(4*8)+(3*2)+(2*8)+(1*4)=91
91 % 10 = 1
So 3382-84-1 is a valid CAS Registry Number.

3382-84-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Tetrahydrorhombifoline

1.2 Other means of identification

Product number -
Other names Tetrahydrorhombifolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3382-84-1 SDS

3382-84-1Downstream Products

3382-84-1Relevant academic research and scientific papers

The Enantioselective Total Synthesis of Bisquinolizidine Alkaloids: A Modular “Inside-Out” Approach

Scharnagel, Dagmar,Goller, Jessica,Deibl, Nicklas,Milius, Wolfgang,Breuning, Matthias

, p. 2432 - 2435 (2018/02/16)

Bisquinolizidine alkaloids are characterized by a chiral bispidine core (3,7-diazabicyclo[3.3.1]nonane) to which combinations of an α,N-fused 2-pyridone, an endo- or exo-α,N-annulated piperidin(on)e, and an exo-allyl substituent are attached. We developed a modular “inside-out” approach that permits access to most members of this class. Its applicability was proven in the asymmetric synthesis of 21 natural bisquinolizidine alkaloids, among them more than ten first enantioselective total syntheses. Key steps are the first successful preparation of both enantiomers of C2-symmetric 2,6-dioxobispidine by desymmetrization of a 2,4,6,8-tetraoxo precursor, the construction of the α,N-fused 2-pyridone by using an enamine-bromoacrylic acid strategy, and the installation of endo- or, optionally, exo-annulated piperidin(on)es.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3382-84-1